EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma

Journal of Hepatology

Volumn 63, Issue 4, 2015, Pages 863-873

  Xia, Hongping ^a   Chen, Jianxiang ^a   Shi, Ming ^b   Gao, Hengjun ^b   Sekar, Karthik ^a   Seshachalam, Veerabrahma Pratap ^a   Ooi, London Lucien P J ^a,c   Hui, Kam M ^a,d,e,f  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SUN YAT SEN UNIVERSITY   (China)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

EDIL3; Epithelial mesenchymal transition; ERK; Hepatocellular carcinoma; TGF ; Tumour angiogenesis

Indexed keywords

EDIL3 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CARRIER PROTEIN; EDIL3 PROTEIN, MOUSE; RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CANCER MODEL; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA CELL; CELL INVASION ASSAY; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; METASTASIS; MICROARRAY ANALYSIS; MOUSE; MOUSE MODEL; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TUBE FORMATION ASSAY; TUMOR XENOGRAFT; WESTERN BLOTTING; WOUND HEALING ASSAY; ANIMAL; BIOSYNTHESIS; C3H MOUSE; EXPERIMENTAL LIVER NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; TIME FACTOR; TUMOR CELL LINE; TUMOR RECURRENCE;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C3H; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TIME FACTORS;

EID: 84941932708     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.05.005     Document Type: Article

References (33)

1. M. Maluccio, and A. Covey Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma CA Cancer J Clin 62 2012 394 399
2. M. Sherman, and J.M. Llovet Smoking, hepatitis B virus infection, and development of hepatocellular carcinoma J Natl Cancer Inst 103 2011 1642 1643
3. A. Villanueva, and J.M. Llovet Liver Cancer in 2013: mutational landscape of HCC - the end of the beginning Nat Rev Clin Oncol 11 2014 73 74
4. J.-C. Nault, and J. Zucman-Rossi Genetics of hepatocellular carcinoma: The next generation J Hepatol 60 2014 224 226
5. J. Bruix, G.J. Gores, and V. Mazzaferro Hepatocellular carcinoma: clinical frontiers and perspectives Gut 63 2014 844 855
6. A.X. Zhu, D.G. Duda, D.V. Sahani, and R.K. Jain HCC and angiogenesis: possible targets and future directions Nat Rev Clin Oncol 8 2011 292 301
7. S. Lamouille, J. Xu, and R. Derynck Molecular mechanisms of epithelial-mesenchymal transition Nat Rev Mol Cell Biol 15 2014 178 196
8. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J Clin Invest 119 2009 1420 1428
9. B.D. Craene, and G. Berx Regulatory networks defining EMT during cancer initiation and progression Nat Rev Cancer 13 2013 97 110
10. A. Fantozzi, D.C. Gruber, L. Pisarsky, C. Heck, A. Kunita, M. Yilmaz, and et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation Cancer Res 74 2014 1566 1575
11. M.H. Yang, C.L. Chen, G.Y. Chau, S.H. Chiou, C.W. Su, T.Y. Chou, and et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma Hepatology 50 2009 1464 1474
12. Y. Li, S. Xu, J. Li, K. Han, H. Pi, L. Zheng, and et al. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease Cell Death Dis 4 2013 e831
13. G. Giannelli The epithelial-mesenchymal transition: Fact or fiction in cancer? Hepatology 50 2009 1344 1346
14. L. Hu, S.H. Lau, C.-H. Tzang, J.-M. Wen, W. Wang, D. Xie, and et al. Association of Vimentin overexpression and hepatocellular carcinoma metastasis Oncogene 23 2004 298 302
15. J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A.A. Margolin, S. Kim, and et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature 483 2012 603 607
16. S.M. Wang, L.L.P. Ooi, and K.M. Hui Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma Clin Cancer Res 13 2007 6275 6283
17. H. Xia, L.L.P.J. Ooi, and K.M. Hui MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer Hepatology 58 2013 629 641
18. P. Paoli, E. Giannoni, and P. Chiarugi Anoikis molecular pathways and its role in cancer progression. Biochimica et Biophysica Acta (BBA)-Molecular Cell Res 1833 2013 3481 3498
19. F. Xiao, Z. Zuo, G. Cai, S. Kang, X. Gao, and T. Li MiRecords: an integrated resource for microRNA-target interactions Nucleic Acids Res 37 2009 D105 D110
20. C. Hidai, T. Zupancic, K. Penta, A. Mikhail, M. Kawana, E.E. Quertermous, and et al. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the αvβ3 integrin receptor Genes Dev 12 1998 21 33
21. M. Rezaee, K. Penta, and T. Quertermous Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin αvβ3 Am J Physiol Heart Circ Physiol 282 2002 H1924 H1932
22. V. Sarrazy, A. Koehler, M.L. Chow, E. Zimina, C.X. Li, H. Kato, and et al. Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction Cardiovasc Res 102 2014 407 417
23. E.Y. Choi, E. Chavakis, M.A. Czabanka, H.F. Langer, L. Fraemohs, M. Economopoulou, and et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment Science 322 2008 1101 1104
24. Y. Aoka, F.L. Johnson, K. Penta, K.-I. Hirata, C. Hidai, R. Schatzman, and et al. The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation Microvasc Res 64 2002 148 161
25. X. Zou, H. Qiao, X. Jiang, X. Dong, H. Jiang, and X. Sun Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer J Biomed Sci 16 2008 33
26. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
27. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.-F. Blanc, and et al. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
28. J.H. Luo, B. Ren, S. Keryanov, G.C. Tseng, U.N. Rao, S.P. Monga, and et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas Hepatology 44 2006 1012 1024
29. J.-C. Sun, X.-T. Liang, K. Pan, H. Wang, J.-J. Zhao, J.-J. Li, and et al. High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients World J Gastroenterol 16 2010 4611
30. M.-X. Feng, M.-Z. Ma, Y. Fu, J. Li, T. Wang, F. Xue, and et al. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation Mol Cancer 13 2014 226
31. C. Neuzillet, A. de Gramont, A. Tijeras-Raballand, L. de Mestier, J. Cros, S. Faivre, and et al. Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas Oncotarget 5 2014 78
32. A. Mazzocca, E. Fransvea, G. Lavezzari, S. Antonaci, and G. Giannelli Inhibition of transforming growth factor β receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation Hepatology 50 2009 1140 1151
33. L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, and et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 Cancer Res 66 2006 11851 11858